Trial intelligence / Profile preview

Anakinra vs prednisone for treatment of gout flares in advanced chronic kidney disease or kidney transplant

2019-002570-31Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Nov 2020
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of anakinra in gout and acute gout flare (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2020; status: active.

02

Drugs

anakinra
03

Conditions

goutacute gout flare

Beyond the preview

Go deeper on 2019-002570-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-002570-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call